Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    18501079 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed PEG-Interferon Alfa-2b in Treating Patients With Metastatic Kidney Cancer
Condition: Kidney Cancer
Intervention: Biological: PEG-interferon alfa-2b

Indicates status has not been verified in more than two years